$57.8 Million is the total value of Canaan Partners X LLC's 4 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IDYA | IDEAYA Biosciences Inc | $36,718,000 | +23.3% | 2,660,713 | 0.0% | 63.52% | +110.1% | |
Berkshire Grey Inc | $20,739,000 | -49.7% | 14,302,523 | 0.0% | 35.88% | -14.2% | ||
ITRM | Iterum Therapeutics plc | $346,000 | -43.7% | 1,733,170 | 0.0% | 0.60% | -4.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IDEAYA Biosciences Inc | 16 | Q3 2023 | 96.1% |
Iterum Therapeutics plc | 12 | Q3 2022 | 6.0% |
NextCure Inc | 8 | Q3 2021 | 82.8% |
Berkshire Grey Inc | 8 | Q2 2023 | 41.8% |
Astra Space Inc | 4 | Q2 2022 | 51.2% |
MONEYLION INC | 2 | Q3 2023 | 3.9% |
View Canaan Partners X LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-10-11 |
13F-HR | 2023-07-13 |
13F-HR | 2023-04-06 |
13F-HR | 2023-02-01 |
13F-HR | 2022-10-31 |
13F-HR | 2022-08-10 |
13F-HR | 2022-04-28 |
13F-HR | 2022-02-03 |
4 | 2022-01-04 |
13F-HR | 2021-11-15 |
View Canaan Partners X LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.